In a small observational study of 24 convalescent COVID-19 patients, significantly elevated syndecan-1 levels were detected after a median of 88 days post-symptom onset compared to healthy controls, whereas no difference in syndecan-1 levels was found between the convalescent patients and patients hospitalised for acute disease. This evidence concerns the gene SDC1 and COVID-19.